NEPT - Neptune Wellness Solutions Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.2100
-0.1100 (-3.31%)
At close: 4:00PM EDT

3.2900 +0.08 (2.49%)
After hours: 5:33PM EDT

Stock chart is not supported by your current browser
Previous Close3.3200
Open3.3000
Bid3.2000 x 800
Ask3.2900 x 800
Day's Range3.1800 - 3.3100
52 Week Range2.3100 - 5.1400
Volume619,791
Avg. Volume683,246
Market Cap256.548M
Beta (3Y Monthly)2.47
PE Ratio (TTM)N/A
EPS (TTM)-0.0680
Earnings DateJan 10, 2017 - Jan 16, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2008-07-24
1y Target Est3.15
Trade prices are not sourced from all markets
  • Neptune Technologies (NEPT) Q3 2019 Earnings Conference Call Transcript
    Motley Foollast month

    Neptune Technologies (NEPT) Q3 2019 Earnings Conference Call Transcript

    NEPT earnings call for the period ending December 31, 2018.

  • Associated Presslast month

    Neptune Tech: Fiscal 3Q Earnings Snapshot

    On a per-share basis, the Laval, Quebec-based company said it had a loss of 4 cents. The krill oil maker posted revenue of $4.9 million in the period. In the final minutes of trading on Wednesday, the ...

  • CNW Grouplast month

    Neptune Announces Third Quarter Results

    Neptune Announces Third Quarter Results

  • ACCESSWIRElast month

    Neptune Technologies & Bioressources Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 13, 2019 / Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on February ...

  • PR Newswire2 months ago

    Neptune to Hold Conference Call to Discuss Third Quarter Results for the Three Months Period Ended December 31, 2018

    LAVAL, QC, Jan. 29, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NEPT) (NEPT.TO), announces that it will be holding a conference call on February 13, 2019 at 5:00 PM (EST) to discuss its third quarter results for the three months period ended December 31, 2018. The third quarter results press release will be issued on the same day after market close. The replay can be accessed online in the Investors section of Neptune's website under Investor Events and Presentations.

  • Here's Why This Small Marijuana Stock Is Soaring Today
    Motley Fool2 months ago

    Here's Why This Small Marijuana Stock Is Soaring Today

    Neptune Wellness Solutions just received a green light from Health Canada, setting the stage for growth.

  • 2 Healthcare Stocks to Buy This Week
    Motley Fool2 months ago

    2 Healthcare Stocks to Buy This Week

    Shares of Amarin and Neptune Wellness Solutions could be stellar buys this week. Here's why.

  • CNW Group2 months ago

    Neptune Receives License to Process Cannabis from Health Canada

    LAVAL, QC , Jan. 7, 2019 /CNW Telbec/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:  NEPT ) (NEPT.TO) is pleased to announce today that it has received its license to process cannabis from Health Canada. "In 2017, we embarked upon a new strategic vision to position the Company in growth markets such as the legal cannabis market and to become a global leader in cannabis extraction, purification and formulation of value-added differentiated products. Today, with our Health Canada processing license in hand, we officially enter the sizable cannabis market and are fully ready to commence commercializing our extraction capabilities.

  • Market Exclusive3 months ago

    Neptune Wellness Solutions Join Hands With Lonza

    Early this month, Neptune Wellness Solutions Inc (NASDAQ:NEPT) moved into the cannabis wellness sector. In a recent news release, Neptune joined hands with Lonza in an IP licensing deal. The deal will also incorporate sale of capsule technology to bolster Neptune’s cannabis production capacity. Neptune Wellness Solutions to add manufacturing facility Lonza is a life […] The post Neptune Wellness Solutions Join Hands With Lonza appeared first on Market Exclusive.

  • CNW Group3 months ago

    Neptune to Expand Manufacturing Capability to Offer Cannabis Oil Capsules in Canada

    LAVAL, QC , Dec. 21, 2018 /CNW Telbec/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NEPT) (NEPT.TO) is pleased to announce today that it has entered into a multi-year IP licencing and capsule sale agreement with Lonza (SWX:LONN), a global leader in the life sciences industry. Thanks to the agreement, Neptune's customers will benefit from Lonza's proprietary Licaps® liquid filled hard capsule technology combined with Neptune's leading extraction and purification capabilities, and significant capacity for the production of cannabis oil. With an initial annual capacity of up to 200 million capsules, this licensing agreement will allow Neptune to set up as large-scale Licaps® manufacturer in the Canadian cannabis sector.

  • Why Marijuana Stock Neptune Wellness Solutions Is Up More Than 30% in 2018
    Motley Fool4 months ago

    Why Marijuana Stock Neptune Wellness Solutions Is Up More Than 30% in 2018

    The chemical-extraction company is striking deals and increasing capacity.

  • CNW Group4 months ago

    Neptune to Participate in Fall 2018 Investor Conferences

    Neptune to Participate in Fall 2018 Investor Conferences

  • Associated Press4 months ago

    Neptune Tech: Fiscal 2Q Earnings Snapshot

    The Laval, Quebec-based company said it had a loss of 3 cents per share. The krill oil maker posted revenue of $5.4 million in the period. In the final minutes of trading on Tuesday, the company's shares ...

  • CNW Group4 months ago

    Neptune Announces Second Quarter Results

    Neptune Announces Second Quarter Results

  • ACCESSWIRE5 months ago

    Cannabis and Biotech Firms Making Investors Boatloads

    HENDERSON, NV / ACCESSWIRE / November 1, 2018 / With so many opportunities at excellent entry points we decided highlighting one of the more interesting companies on the market, Endonovo Therapeutics, Inc. (ENDV). There are several other diseases the Sofpulse might help with including counteracting the effects of nonalcoholic steatohepatitis (NASH). In a pre-clinical study, one to 2 weeks of treatment with Sofpulse®, the non-invasive proprietary device of Endonovo Therapeutics, appeared to counteract several of the disease signs associated with NASH-associated liver damage.

  • PR Newswire5 months ago

    Neptune to Hold Conference Call to Discuss Second Quarter Results for the Three Months Period Ended September 30, 2018

    LAVAL, QC , Oct. 31, 2018 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), announces that it will be holding a conference call ...

  • PR Newswire5 months ago

    Neptune to Exhibit and Present at 2018 Montreal Cannabis Expo

    LAVAL, QC, Oct. 22, 2018 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune") (NASDAQ: NEPT) (NEPT.TO) is pleased to announce its participation at the Montreal Cannabis Expo, taking place October 26 and 27, 2018 in Montreal, Quebec. The first-ever cannabis industry tradeshow in Montreal will bring together current and future licensed producers, investors, industry professionals and media for the first time following legalization of cannabis for adult use in Canada to showcase their projects and expertise and engage around the industry's most salient issues.